US8987232B2ActiveUtilityPatentIndex 73
Agent for ameliorating brain hypofunction
Est. expirySep 4, 2028(~2.2 yrs left)· nominal 20-yr term from priority
A61P 25/28A61K 31/7008A61P 25/00
73
PatentIndex Score
5
Cited by
16
References
4
Claims
Abstract
Provided are effective and highly safe agents, medicaments and the like for ameliorating various disorders caused by brain hypofunction. Also provided is a preventing or ameliorating agent for brain hypofunction containing N-acetyl-D-mannosamine, a pharmaceutical composition for preventing, ameliorating or treating disorders due to brain hypofunction, containing an effective amount of N-acetyl-D-mannosamine and a pharmaceutically acceptable carrier, and a food comprising N-acetyl-D-mannosamine added thereto.
Claims
exact text as granted — not AI-modifiedThe invention claimed is:
1. A method of ameliorating or treating a sleep interruption due to premature arousal in a subject in need thereof, comprising administering an effective amount of N-acetyl-D-mannosamine to the subject.
2. A method of ameliorating a sleep interruption due to premature arousal in a subject in need thereof, comprising allowing an effective amount of N-acetyl-D-mannosamine to be taken by the subject.
3. The method of claim 2 , wherein the subject is a human.
4. The method of claim 1 , wherein the subject is a human.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.